美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

VanEck Biotech ETF

234.14

-2.5806-1.09%

盤後：234.480.3406+0.15%19:30 EDT

成交量：2,519

成交額：59.20萬

市值：4.93億

市盈率：- -

高：237.15

開：236.66

低：234.01

收：236.72

52周最高：244.35

52周最低：160.91

股本：210.65萬

流通股本：210.65萬

量比：0.72

換手率：0.12%

股息：0.95

股息率：0.40%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

吉利德高管在電話會議中宣佈：全年HIV業務增長預期上調至9%-10%，此前指引為8%

吉利德高管：距FDA PDUFA日期僅剩五個月，Anito-Cel細胞療法上市籌備工作已全面啓動

吉利德科學第二季度調整後每股收益-6.75美元，高於IBES預估-7.24美元

安進(AMGN)股票8月4日收盤上漲3.03%：關鍵驅動因素揭曉

TradingKey中文

吉利德科學：季度調整後每股虧損6.75美元，反映近期收購帶來的每股9.08美元知識產權研發及税務支出

安進第二季度銷售額增長9%，利潤超出華爾街預期

吉利德第二季度銷售額增長8%，超出華爾街預期

前瞻：安進股價在財報公布前走高

Vertex 擴大領導團隊，為下一階段增長注入強勁動力

重點關注個股：Palantir、SpaceX、滙豐控股

阿斯利康擬與百時美施貴寶4000億美元重組傳聞背後：專利懸崖、產品短板倒逼，AZ端反對聲大

非阿片止痛藥新鋭Latigo(LTGO.US)IPO擬最高募資2.88億美元，Nav1.8抑制劑劍指福泰製藥(VRTX.US)百億市場

福泰製藥重申2026年全年指引：GAAP與非GAAP研發、AI研發及銷售管理費用預期不變

福泰製藥：基於現行關税法規，2026年指引中關税成本影響依然微乎其微

Vertex憑藉囊性纖維化藥物的強勁表現上調年度營收預期

加州最高法院在「創新義務」案中裁定吉利德勝訴

加州最高法院裁定吉利德科學勝訴，HIV藥物「創新責任」案塵埃落定

傑富瑞因索馬圖林面臨的競爭風險，將伊普森評級下調至「表現遜於大盤」

安進7月遭網絡攻擊部分患者信息被盜

安進：部分數據已遭竊取，其中包括專有數據、患者受保護健康信息及其他信息。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BBH/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":234.1394,"timestamp":1789761600000,"preClose":236.72,"halted":0,"volume":2519,"hourTrading":{"tag":"盘后","latestPrice":234.48,"preClose":234.1394,"latestTime":"19:30 EDT","volume":18,"amount":4208.8058,"timestamp":1789774205696,"change":0.3406,"changeRate":0.001455,"amplitude":0},"delay":0,"changeRate":-0.010901486988847601,"floatShares":2106503,"shares":2106503,"eps":0,"marketStatus":"休市中","change":-2.5806,"latestTime":"09-18 16:00:00 EDT","open":236.66,"high":237.145,"low":234.01,"amount":592022.03016,"amplitude":0.013243,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":236.72,"sharesOutstanding":1976503,"nav":234.20447,"aum":469931967.75,"dividendRate":0.004048,"bidAskSpread":0.001092,"preHourTrading":{"tag":"盘前","latestPrice":236.72,"preClose":236.72,"latestTime":"04:00 EDT","volume":1,"amount":236.72,"timestamp":1789718407582,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":234.48,"preClose":234.1394,"latestTime":"19:30 EDT","volume":18,"amount":4208.8058,"timestamp":1789774205696,"change":0.3406,"changeRate":0.001455,"amplitude":0},"volumeRatio":0.7249337757599275,"impliedVol":0.1845,"impliedVolPercentile":0.3347},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2106503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7249337757599275,"shares":2106503,"dividePrice":0.9478,"high":237.145,"amplitude":0.013243,"preClose":236.72,"low":234.01,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":234.1394,"eps":0,"divideRate":0.004048,"volume":2519,"delay":0,"ttmEps":0,"open":236.66,"prevYearClose":189.2649,"prevWeekClose":229.3922,"prevMonthClose":236.396,"prevQuarterClose":203.2373,"fiveDayClose":229.3922,"twentyDayClose":237.1125,"sixtyDayClose":194.9611},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1135051692","title":"吉利德高管在電話會議中宣佈：全年HIV業務增長預期上調至9%-10%，此前指引為8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135051692","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135051692?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:42","pubTimestamp":1785876147,"startTime":"0","endTime":"0","summary":"吉利德（Gilead Sciences）高管在电话会议上透露，公司已将全年HIV业务增长预期上调至9%至10%的区间。这一调整较此前8%的增长指引显著提升，展现了公司对该业务领域强劲势头的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","IBBQ","LU1839511570.USD","LU0965508806.USD","LU1023059063.AUD","LU1066051498.USD","IE00B19Z3581.USD","LU0965509010.AUD","SG9999015986.USD","BK4583","LU0109394709.USD","IE0002270589.USD","LU2468319806.SGD","IBB","IE00B3T34201.USD","LU0965509101.SGD","LU1778281490.HKD","IE00BZ1G4Q59.USD","LU1430594728.SGD","LU2089984988.USD","BIB","BK4588","IE00BKVL7J92.USD","LU0965509283.SGD","LU1934455194.USD","LU1037948897.HKD","BK4585","LU0889565916.HKD","SG9999015945.SGD","LU0882574055.USD","LU2087621335.USD","LU2324357040.USD","BK4568","LU1934455863.HKD","LU0823416689.USD","MEDI","LU0289739699.SGD","BBH","SG9999015978.USD","LU0234570918.USD","LU0058720904.USD","BK4139","LU1057294990.SGD","LU2112291526.USD","BK4578","LU1066053197.SGD","LU1674673428.USD","GILD","BK4566","LU1934455277.USD","IE00B7SZLL34.SGD","LU1061106388.HKD","LU1585245621.USD","LU0122379950.USD","SG9999015952.SGD","IE00BSNM7G36.USD","LU0320765992.SGD","LU0114720955.EUR","LU1674673691.USD","TMED","BK4532","LU1037948541.HKD","BMED","BK4550","LU1571399168.USD","IE00B19Z3B42.SGD","LU0861579265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145483121","title":"吉利德高管：距FDA PDUFA日期僅剩五個月，Anito-Cel細胞療法上市籌備工作已全面啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=1145483121","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145483121?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:42","pubTimestamp":1785876146,"startTime":"0","endTime":"0","summary":"吉利德科学（Gilead Sciences）高管透露，针对其重磅细胞疗法Anito-Cel的上市准备工作已全面铺开，目前距离美国食品药品监督管理局（FDA）设定的PDUFA目标日期仅剩五个月时间。这一消息源自公司近期召开的电话会议。\n在会议中，高管进一步强调，公司正紧锣密鼓地推进各项筹备事项，以确保一旦获批，该疗法能够迅速进入市场。Anito-Cel作为一种前沿的细胞治疗产品，被视为吉利德在肿瘤学领域布局的关键一环。随着最终审批日期的临近，市场对这款疗法的商业化前景给予高度关注，而吉利德方面则展现出对既定时间表与执行能力的充分信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0289739699.SGD","BBH","LU0122379950.USD","IBB","TMED","BK4568","LU0882574055.USD","BK4566","SG9999015986.USD","LU1061106388.HKD","LU0109394709.USD","BK4585","BK4583","BK4578","GILD","LU0889565916.HKD","LU0114720955.EUR","BK4532","LU1674673428.USD","TBXU","LU2112291526.USD","SG9999015952.SGD","LU1778281490.HKD","LU1066053197.SGD","LU1023059063.AUD","LU1430594728.SGD","LU2089984988.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU2324357040.USD","LU0965509010.AUD","LU1934455863.HKD","IE00BKVL7J92.USD","BIB","LU0965509101.SGD","LU1037948897.HKD","LU1674673691.USD","LU2087621335.USD","LU1585245621.USD","LU1934455277.USD","LU2468319806.SGD","IBBQ","LU0861579265.USD","LU0058720904.USD","LU1037948541.HKD","LU1839511570.USD","MEDI","BMED","BK4139","SG9999015945.SGD","LU1057294990.SGD","LU0965509283.SGD","LU1066051498.USD","LU1571399168.USD","LU0234570918.USD","LU0965508806.USD","BK4550","LU0320765992.SGD","SG9999015978.USD","LU0823416689.USD","LU1934455194.USD","IE00B3T34201.USD","IE0002270589.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163992816","title":"吉利德科學第二季度調整後每股收益-6.75美元，高於IBES預估-7.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163992816","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163992816?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:17","pubTimestamp":1785874678,"startTime":"0","endTime":"0","summary":"8月4日，吉利德科学（Gilead Sciences）公布第二季度产品销售额达76.27亿美元。第二季度调整后每股收益为-6.75美元，优于IBES预估的-7.24美元。","market":"us","thumbnail":"https://static.tigerbbs.com/9e7ba54e8539d48dd315975babea7852","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/9e7ba54e8539d48dd315975babea7852"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","LU1057294990.SGD","BK4583","LU1037948541.HKD","IE00B19Z3B42.SGD","LU0861579265.USD","LU1674673428.USD","LU0965508806.USD","LU1061106388.HKD","SG9999015945.SGD","TMED","LU0823416689.USD","LU0320765992.SGD","IE0002270589.USD","BK4578","LU0889565916.HKD","LU1778281490.HKD","BK4139","LU0965509283.SGD","BIB","LU0109394709.USD","IE00BZ1G4Q59.USD","IBBQ","LU1023059063.AUD","LU1934455863.HKD","LU2087621335.USD","MEDI","LU0058720904.USD","LU2112291526.USD","LU0965509101.SGD","LU1571399168.USD","GILD","TBXU","LU0114720955.EUR","LU0289739699.SGD","BK4532","LU1066051498.USD","LU1839511570.USD","LU1066053197.SGD","LU0234570918.USD","IE00B19Z3581.USD","LU0122379950.USD","SG9999015952.SGD","LU2324357040.USD","BK4566","BBH","IE00BKVL7J92.USD","LU1934455194.USD","BK4585","IE00B7SZLL34.SGD","LU0965509010.AUD","LU1430594728.SGD","LU1585245621.USD","BK4588","LU1934455277.USD","LU2468319806.SGD","LU2089984988.USD","SG9999015978.USD","BK4568","BMED","BK4550","LU0882574055.USD","LU1674673691.USD","IE00BSNM7G36.USD","SG9999015986.USD","IBB","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657627865","title":"安進(AMGN)股票8月4日收盤上漲3.03%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2657627865","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657627865?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:16","pubTimestamp":1785874591,"startTime":"0","endTime":"0","summary":"• 安进公布的第二季度业绩超出了市场对营收和每股收益的共识预期。\n• 一款代谢健康候选药物的积极中期临床数据推动了其股价上涨。\n• 全年营收达到367.5亿美元，该公司的净利润排名位列第十。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262074405-market-movers-amgn-20260804","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","BK4599","BK4533","BK4588","LU2468319806.SGD","LU1057294990.SGD","BIB","LU2089984988.USD","IBB","BBH","LU1023059063.AUD","LU2112291526.USD","BK4534","LU0109394709.USD","BK4581","IE0009355771.USD","BK4585","IBBQ","IE00B2B36J28.USD","SG9999001440.SGD","LU0289739699.SGD","LU2242652126.USD","IE0002141913.USD","TBXU","IE00B4R5TH58.HKD","LU2242646821.SGD","LU1571399168.USD","LU0058720904.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","AMGN","IE00BJT1NW94.SGD","PJP","LU0320765992.SGD","PBE","LU0868494617.USD","BK4566","LU1983299246.USD","IE00BFTCPJ56.SGD","LU0122379950.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108344321","title":"吉利德科學：季度調整後每股虧損6.75美元，反映近期收購帶來的每股9.08美元知識產權研發及税務支出","url":"https://stock-news.laohu8.com/highlight/detail?id=1108344321","media":"美股速递","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108344321?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:04","pubTimestamp":1785873878,"startTime":"0","endTime":"0","summary":"吉利德科学（Gilead Sciences）最新季度业绩揭晓。数据显示，公司调整后每股收益为-6.75美元。这一数字背后，折射出近期收购活动所产生的重大财务影响——具体而言，每股9.08美元的知识产权研发成本与税务费用被计入。这些支出，均与公司近期完成的收购交易紧密相关。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","LU1037948541.HKD","IE00B7SZLL34.SGD","IBBQ","IE00B19Z3581.USD","MEDI","LU1585245621.USD","LU0122379950.USD","SG9999015952.SGD","LU1674673428.USD","LU1061106388.HKD","LU1571399168.USD","BBH","IE00BKVL7J92.USD","BK4578","LU0109394709.USD","LU1934455194.USD","LU0889565916.HKD","LU1674673691.USD","BK4532","LU0320765992.SGD","BK4566","LU0965508806.USD","LU1430594728.SGD","LU0058720904.USD","LU1057294990.SGD","IE00BZ1G4Q59.USD","BK4585","LU0965509101.SGD","LU1778281490.HKD","LU2112291526.USD","BK4588","LU1839511570.USD","TBXU","SG9999015945.SGD","LU0289739699.SGD","BK4568","SG9999015986.USD","LU1037948897.HKD","BIB","GILD","IE00B3T34201.USD","BMED","LU0965509283.SGD","LU2468319806.SGD","LU0114720955.EUR","BK4550","BK4139","LU1023059063.AUD","BK4583","LU0234570918.USD","LU1934455863.HKD","SG9999015978.USD","LU0823416689.USD","LU2324357040.USD","LU1066051498.USD","LU2087621335.USD","IBB","IE00B19Z3B42.SGD","LU0965509010.AUD","LU1934455277.USD","LU2089984988.USD","LU0861579265.USD","IE00BSNM7G36.USD","TMED","IE0002270589.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657569101","title":"安進第二季度銷售額增長9%，利潤超出華爾街預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2657569101","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657569101?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:04","pubTimestamp":1785873843,"startTime":"0","endTime":"0","summary":"安进第二季度销售额增长9%，利润超出华尔街预期经调整的每股收益为6.29美元，超出分析师预期上调全年营收和利润预期安进公司停止开发第二款实验性减肥药AMG 513Deena Beasley路透8月4日-安进公司周二公布，受降胆固醇药物Repatha、骨质疏松药物Evenity以及罕见病药物需求推动，第二季度销售额增长9%。季度营收同比增长10%，达到101亿美元，超过了华尔街94.2亿美元的平均预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4T4411XI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU2242646821.SGD","BBH","AMGN","BK4533","LU2089984988.USD","BK4588","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE0009355771.USD","LU1057294990.SGD","BK4566","LU1983299246.USD","IE00B4R5TH58.HKD","LU0058720904.USD","BK4599","IBB","BK4581","LU1061106388.HKD","PJP","BIB","LU1571399168.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU0109394709.USD","LU2468319806.SGD","IE0002141913.USD","LU0122379950.USD","BK4534","LU0289739699.SGD","LU0868494617.USD","LU0889565916.HKD","IBBQ","BK4585","LU2112291526.USD","TBXU","SG9999001440.SGD","04332","LU2242652126.USD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657820569","title":"吉利德第二季度銷售額增長8%，超出華爾街預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2657820569","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657820569?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 04:02","pubTimestamp":1785873759,"startTime":"0","endTime":"0","summary":"据LSEG数据显示，该公司总营收增长10%至78亿美元，超出华尔街预期的74亿美元。第二季度，吉利德公布经调整后每股亏损为6.75美元，而华尔街分析师平均预期为7.24美元。另一款较早上市的艾滋病口服药Descovy的季度销售额猛增48%，达到9.67亿美元，增幅超出预期。吉利德表示，其肝病产品组合的销售额增长10%，达到8.77亿美元，而细胞疗法产品的销售额则下降14%，至4.17亿美元，这反映出市场竞争加剧。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4T4411XD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU1037948897.HKD","SG9999015952.SGD","IBBQ","IE00BSNM7G36.USD","LU0823416689.USD","BK4139","IE00B19Z3B42.SGD","BK4583","IE00BZ1G4Q59.USD","LU0965509283.SGD","SG9999015986.USD","BBH","LU1585245621.USD","GILD","LU0965509101.SGD","LU0965509010.AUD","LU2089984988.USD","LU0058720904.USD","LU0114720955.EUR","LU1061106388.HKD","LU0234570918.USD","BK4585","TMED","LU2468319806.SGD","LU1778281490.HKD","LU0882574055.USD","LU0109394709.USD","LU1066051498.USD","IE00B3T34201.USD","LU0320765992.SGD","LU0889565916.HKD","LU0965508806.USD","LU2324357040.USD","BK4568","LU0289739699.SGD","LU2112291526.USD","MEDI","BIB","BK4588","LU1066053197.SGD","SG9999015978.USD","LU1571399168.USD","IE00B19Z3581.USD","LU1674673428.USD","TBXU","LU1934455277.USD","BMED","BK4566","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657568090","title":"前瞻：安進股價在財報公布前走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2657568090","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657568090?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 01:30","pubTimestamp":1785864614,"startTime":"0","endTime":"0","summary":"BUZZ-前瞻：安进股价在财报公布前走高8月4日-** 安进AMGN.O股价周二上涨2.2%，该公司将于收盘后公布季度财报，投资者正密切关注其试验性减肥药的最新进展** 据伦敦证券交易所集团（LSEG）预测，这家生物技术公司预计将公布季度营收增长3%至94.2亿美元，而调整后每股收益则可能从6.02美元降至5.62美元** 在过去8个季度中，AMGN有7个季度达到了或超过了每股收益预期，最近一次未","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4S4411RA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","IE0009355771.USD","AMGN","IBB","LU1061106388.HKD","IE0002141913.USD","BIB","IBBQ","PJP","LU2468319806.SGD","LU0889565916.HKD","BK4599","LU0868494617.USD","LU2089984988.USD","LU0122379950.USD","LU2242652126.USD","LU1057294990.SGD","LU0058720904.USD","LU1983299246.USD","LU2112291526.USD","BK4588","BK4534","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU1571399168.USD","LU2242646821.SGD","LU0320765992.SGD","TBXU","IE00BJJMRZ35.SGD","BK4566","LU0109394709.USD","SG9999001440.SGD","IE00BJT1NW94.SGD","BK4581","IE00B2B36J28.USD","BK4139","IE00B4R5TH58.HKD","BK4585","BBH","PBE","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117517951","title":"Vertex 擴大領導團隊，為下一階段增長注入強勁動力","url":"https://stock-news.laohu8.com/highlight/detail?id=1117517951","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117517951?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 20:02","pubTimestamp":1785844955,"startTime":"0","endTime":"0","summary":"宾夕法尼亚州普鲁士王，2026年8月4日——全球间接税与合规领域的“决策到防御”先锋，Vertex Inc.，今日宣布其领导团队迎来三位新成员，旨在为公司下一阶段的蓬勃发展提供坚实支撑。他们的加入，将通过对人才、区域运营及技术创新的领导力扩展，进一步强化 Vertex 的全球增长战略。在 Vertex，她将负责全球人才与企业文化战略，构建起推动业务规模化发展所需的人才储备和组织能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX","LU0757428866.USD","BK4120","LU2089984988.USD","BBH","LU0109394709.USD","BK4585","LU2236285917.USD","LU0234570918.USD","03160","LU0823416689.USD","VERX","LU0058720904.USD","LU0256863811.USD","LU0320765992.SGD","LU0079474960.USD","SG9999013999.USD","LU2362541273.HKD","IE00BZ9MQY76.HKD","BK4084","BK4533","TISI","LU2468319806.SGD","LU2237438978.USD","IBB","LU1035775433.USD","LU1778281490.HKD","IE0009355771.USD","IE00B2B36J28.USD","LU0289739699.SGD","PW","SGXZ57979304.SGD","IE0002270589.USD","TBXU","LU0432979614.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","PBE","LU1430594728.SGD","IE00B19Z3B42.SGD","IE00B19Z9Z06.USD","LU2417539215.USD","BK4139","TM","BIB","LU1093756168.USD","LU1093756325.SGD","BK4604","IBBQ","IDNA","LU1674673428.USD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","LU2362541513.USD","LU1815336091.USD","LU1559883803.SGD","SG9999001176.USD","BK4023","LU0417517546.SGD","LU1674673691.USD","BK4588","BK4555","LU1069344957.HKD","IE00B19Z9P08.USD","LU2456880835.USD","SG9999001176.SGD","GNMX","IE0002141913.USD","LU0061475181.USD","BK4234","LU2324357040.USD","LU2462157665.USD","IE00BJT1NW94.SGD","LU0566484027.USD","IE00B894F039.SGD","BK4567","BK4099","BK4532","LU1585245621.USD","IE00BFTCPJ56.SGD","LU2362540622.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103561229","title":"重點關注個股：Palantir、SpaceX、滙豐控股","url":"https://stock-news.laohu8.com/highlight/detail?id=1103561229","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103561229?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 17:28","pubTimestamp":1785835721,"startTime":"0","endTime":"0","summary":"**Palantir Technologies **：这家软件公司昨日盘后公布了强劲的财报，业绩表现亮眼，推动其盘前股价飙升逾15%。财报发布后，其股价微幅上涨。**汇丰控股 **：这家英国银行公布季度利润增长，并宣布了高达10亿美元的股票回购计划，但由于回购规模令部分投资者感到失望，其股价小幅走低。Segro股价小幅上扬，而安博盘前股价则基本持平。**辉瑞 、默沙东 、安进  与 BioNTech **：这些制药公司将在今日美股开盘前公布财报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USRT","SPCG","IE00BJT1NW94.SGD","JRE","BK4532","BAI","IE0009355771.USD","LU1244550221.USD","AMDG","LU1291159041.SGD","IE00BJTD4N35.SGD","IE00BMPRXQ63.HKD","LU0320765646.SGD","FAI","LU0868494708.USD","IE0001KFT4U8.USD","LU1988902786.USD","OZEM","PLD","AMYY","PLTR","04332","IE00BLSP4452.SGD","LU0912757837.SGD","LU2361044949.HKD","WTRE","LU2347655073.USD","LU2247934214.USD","IYH","LU0719512351.SGD","LU1989764748.USD","TBXU","LOFF","URE","WSPC","LU0320765992.SGD","TEK","BK4550","LU1894683348.USD","AMDW","LU0122379950.USD","BK4585","LU0321505868.SGD","PLTY","SSPC","LU0976567544.SGD","SCHH","VNQ","LU2491050071.SGD","LU0109392836.USD","LU0203347892.USD","LU1951200564.SGD","IE00BN8TJ469.HKD","LU2089984988.USD","SGXZ57979304.SGD","ORBX","LU0211326755.USD","IE00BQXX3D17.EUR","AMDU","LU0642271901.SGD","ARTY","LU1732799900.SGD","HSBC","LU2125909247.SGD","LU1430594728.SGD","SG9999014575.USD","SPRE","IE00BMPRXR70.SGD","LU2931357623.SGD","LU1061106388.HKD","BK4599","USXF","CHPS","LU0823421333.USD","AMDL","LU1861215975.USD","BK4610","BK4575","LU0823434583.USD","INDS","LU1804176565.USD","LU0786609619.USD","LU0006306889.USD","LU2236285917.USD","LU0321505439.SGD","03160","REIT","PLTI","SOXY","LU0208291251.USD","LU0985320562.USD","IBBQ","LU0274383776.USD","LU2461242641.AUD","IYRI","LU0109394709.USD","LU2106854487.HKD","LU0058720904.USD","BK4224","LU2108987350.USD","LU1989772840.SGD","AMD","LU0889565916.HKD","LU0081259029.USD","FRI","DTRE","RXL","WARP","DPRE","LU1037948897.HKD","LU0306806265.USD","TRUH","LU0130102774.USD","LU0211326839.USD","IE00BMPRXN33.USD","LU0310800965.SGD","SHLD","IE00B894F039.SGD","LU1941712348.USD","SG9999015341.SGD","HSBH","LU0889565833.HKD","SGXZ51526630.SGD","BK4089","GQRE","PAWZ","LU2347655156.SGD","LU0130517989.USD","RNTY","IE00B19Z9P08.USD","PLTW","LU1883839398.USD","SG9999001440.SGD","PLTZ","IE00BZ1G4Q59.USD","LU0170899867.USD","MCD","LU1718418525.SGD","LU0979878070.USD","LU1093756325.SGD","DFAR","AMDY","LU0889566641.SGD","FHLC","BK4571","LU1244550494.USD","QQQA","VGSR","LU1974910355.USD","PLTG","LU1267930813.SGD","LU1880398471.USD","LU1983260115.SGD","BK4581","LU1941712264.USD","LU2361044865.SGD","LU2596442595.SGD","IE00B5949003.HKD","BK4534","AMDS","LU2098885051.SGD","BK4566","LU1116320901.HKD","AMUU","PJP","LEGR","JPRE","GUNZ","AIS","LU2125909593.SGD","SG9999011175.SGD","IE00BJJMRZ35.SGD","LU2362541513.USD","LU2360107168.USD","SGXZ81514606.USD","LU1880398554.USD","SPOT","LU1066051498.USD","BP.UK","LU0985481810.HKD","LU0210536198.USD","LU2361045086.USD","LU1923622614.USD","LU2468319806.SGD","LU1917777945.USD","IE00BQXX3F31.USD","GAMR","SMH","WUGI","LU0070302665.USD","LU0456855351.SGD","LU0823416689.USD","IYR","LU0266013472.USD","BK4554","IE00BBT3K403.USD","LU1989764664.SGD","TTEQ","LU0124676726.USD","LU2133065610.SGD","JDOC","LU2355687059.USD","LU1232071149.USD","AMGN","LU0203345920.USD","PBE","AMDD","FTXH","IXJ","SG9999013999.USD","LU0859254822.USD","SG9999001176.SGD","LU0265550359.USD","LU1074936037.SGD","LU2458330243.SGD","SG9999015358.SGD","IE0002141913.USD","BK4543","WISE","PPTY","LU1303367103.USD","SOXX","XLV","PLTA","LU1066051225.USD","LU1035773651.USD","PSR","BK4516","IE00B4R5TH58.HKD","SG9999014567.USD","BK4209","LU0980610538.SGD","LU0477156953.USD","IE00BSNM7G36.USD","LU2054465674.USD","LU0265550946.USD","IBB","LU0390134368.USD","LU0320765489.SGD","CNAV","BIB","LU0082616367.USD","SPCH","SG9999002232.USD","BK4535","RITA","BK4108","00005","BK4559","PSI","LU1093756168.USD","LU2458330169.SGD","LU2265009873.SGD","CRED","IGV","LU0256863811.USD","IE00BKVL7J92.USD","LU1894683264.USD","LU2264538146.SGD","BK4171","LU1057294990.SGD","LU2896262040.SGD","LU1934455277.USD","LU0174119429.USD","HRTS","LU2089985449.USD","LU0965509283.SGD","REET","LU0251132253.USD","PFE","LU1803068979.SGD","SG9999002224.SGD","SGXZ99366536.SGD","BK4547","CLIM","LU0306807586.USD","IE00B19Z3B42.SGD","TM","BK4548","LU1699723380.USD","LU2491050154.USD","LU1037948541.HKD","LU1852331112.SGD","XNTK","PLTU","LU1989772923.USD","IE00BJJMRX11.SGD","LU0417517546.SGD","RWR","BK4612","LU2023250504.SGD","LU0211331839.USD","LU0965509010.AUD","LU1989771016.USD","LU0792757196.USD","SG9999001424.SGD","IETC","LU2324357040.USD","LU1951198990.SGD","IE00B7KXQ091.USD","LU0052756011.USD","LU1162221912.USD","IE00BFTCPJ56.SGD","LU1201861249.SGD","BK4604","LU1732800096.USD","SG9999001176.USD","BK4555","SPAX","IE00B3T34201.USD","IE00BJJMRY28.SGD","BK4573","AVRE","LU0795875086.SGD","AIPI","LU1069347547.HKD","PPH","BBH","LU2362541273.HKD","LU1267930227.SGD","LU2362540622.SGD","BK4512","IE00B19Z9Z06.USD","BK4529","SG9999014542.SGD","PLT","LU1983299246.USD","LU2250418816.HKD","LU0198837287.USD","BK4533","LU0965508806.USD","BK4099","LU0689626769.HKD","TRUR","IE00B2B36J28.USD","BK4141","MARS","LU2360106780.USD","XLRE","LU2462591350.SGD","BK4521","SPCX","BK4567","IE00BFSS8Q28.SGD","SG9999003800.SGD","LU1571399168.USD","LU2125154935.USD","BNTX","PLOO","BMED","IE00BLSP4239.USD","BK4007","LU1242518931.SGD","DAMD","LU0965509101.SGD","BK4568","BK4614","SG9999014559.SGD","LU0289739699.SGD","IE00B1BXHZ80.USD","LU0127658192.USD","LU2125154778.USD","SPOG","LU2242649171.HKD","PTIR","LU0056508442.USD","PLTD","LU2279689827.SGD","LU1923623000.USD","LU0128525689.USD","IHE","IE0009356076.USD","SPCF","BK4592","BK4207","LU1064131342.USD","ILDR","BK4551","LU0795875169.SGD","SPCQ","LU0106261372.USD","LU2112291526.USD","ERET","LU1934455863.HKD","AIQ","BK4605","LU0942090050.USD","IE00BFSS7M15.SGD","LU0823421416.USD","IE0004445239.USD","LU0868494617.USD","EYES","GDOC","LU2023250843.SGD","TRFK","LU0048584097.USD","LU0133085943.USD","BK4588","CHAT","LU2357627491.SGD","BBRE","LU0726765562.USD","LU2290526834.HKD","LU2433249047.HKD","LU1066053197.SGD","LU1861558580.USD","BK4504","IE000M9KFDE8.USD","DFGR","LU1316542783.SGD","LU2242646821.SGD","ICF","IE00BJTD4V19.USD","LU0648001328.SGD","FTXL","LU1585245621.USD","LU0861579265.USD","SPCM","LU2860962120.EUR","LU0234572021.USD","IE0004445015.USD","LU0225284248.USD","IE00B19Z3581.USD","LU2360032135.SGD","LU1116320737.USD","FREL","LU1023059063.AUD","LU1244550577.SGD","LU2242652126.USD","MRK","LU0823434740.USD","LU1861220033.SGD","LU0098860793.USD","BK4139","LU1929549753.HKD","LU1934455194.USD","LU2491049909.HKD","LU1861559042.SGD","LU1242518857.USD","BK4613","PLYY","SMHX","LU0496365809.HKD","IE0002270589.USD","IE00BQXX3C00.GBP","LU0238689110.USD","IE00BZ9MQY76.HKD","LU0432979614.USD","LU1066051811.HKD","LU0225771236.USD","RWO","BK4023","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656080539","title":"阿斯利康擬與百時美施貴寶4000億美元重組傳聞背後：專利懸崖、產品短板倒逼，AZ端反對聲大","url":"https://stock-news.laohu8.com/highlight/detail?id=2656080539","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656080539?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 17:26","pubTimestamp":1785835565,"startTime":"0","endTime":"0","summary":"蓝鲸新闻记者联系了阿斯利康方面，对方拒绝对此置评。此外，BMS有神经管线与Eliquis后续心血管资产，可补足AZ在相关领域的短板。据BMO资本在研报中指出，两家公司都没有足够的财务实力直接收购对方，预计阿斯利康能掏出约370亿美元，而百时美施贵宝约为320亿美元，远低于搞定一桩价值4000亿美元合并所需的资金。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1785835141389493693","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BME","RSPH","LU0985481810.HKD","LU1093756168.USD","TMED","TRUH","LU1670711123.USD","LU0128525929.USD","LU0225284248.USD","LU1868837300.USD","FXH","LU2242646821.SGD","BMY","LU2462157665.USD","AZN","PBPH","MEDI","FTXH","IE00B2B36J28.USD","AZNH","LU0267386448.USD","LU1868836591.USD","LU0868494617.USD","LU0432979614.USD","APXH","LU1032466523.USD","PJP","LU1868836914.USD","BBP","IE00BJJMRZ35.SGD","LU1585245621.USD","LU0321505439.SGD","IYH","BK4559","LU2237443382.USD","FHLC","LU0321505868.SGD","LU0882574055.USD","LU1093756325.SGD","LU2089984988.USD","LU2237443895.HKD","LU2596442595.SGD","JDOC","PPH","AZ","LU1670710588.SGD","BK4588","BBH","IHE","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656539622","title":"非阿片止痛藥新鋭Latigo(LTGO.US)IPO擬最高募資2.88億美元，Nav1.8抑制劑劍指福泰製藥(VRTX.US)百億市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2656539622","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656539622?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 16:59","pubTimestamp":1785833974,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0289739699.SGD","LU1674673428.USD","REDS","LU1778281490.HKD","IE00BZ9MQY76.HKD","LU0234570918.USD","LU0823416689.USD","IBB","IE0002141913.USD","BIB","IBBQ","LU0256863811.USD","LU2468319806.SGD","SG9999013999.USD","LU0889565916.HKD","VRTX","LU0058720904.USD","IE00B19Z3581.USD","LU2362541273.HKD","IE00B19Z9Z06.USD","BK4532","IDNA","BK4588","IE00B19Z9P08.USD","BK4127","IE00BFTCPJ56.SGD","LU1430594728.SGD","SGXZ57979304.SGD","IPOS","TBXU","IE00BJJMRZ35.SGD","FRHC","KCE","LU0417517546.SGD","LU2456880835.USD","IE00BJT1NW94.SGD","LU2362541513.USD","LU1093756168.USD","BK4139","LU1093756325.SGD","LU1585245621.USD","IE00B4R5TH58.HKD","BK4585","LTGO","LU2324357040.USD","BBH","PBE","IE00B19Z3B42.SGD","GNMX","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126575276","title":"福泰製藥重申2026年全年指引：GAAP與非GAAP研發、AI研發及銷售管理費用預期不變","url":"https://stock-news.laohu8.com/highlight/detail?id=1126575276","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126575276?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 04:07","pubTimestamp":1785787669,"startTime":"0","endTime":"0","summary":"福泰制药（Vertex Pharmaceuticals）再次确认其2026年全年财务指引。在涵盖GAAP及非GAAP口径下的研发支出、AI研发投入以及销售、一般及管理费用（SG&A）方面，该公司均维持此前预期不变，未作出任何调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","SGXZ57979304.SGD","SG9999001176.SGD","GNMX","IE00B4R5TH58.HKD","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","LU1674673428.USD","IE00B19Z9Z06.USD","LU0432979614.USD","IE00B894F039.SGD","LU0823416689.USD","LU0320765992.SGD","LU1035775433.USD","IE0002270589.USD","LU0889565916.HKD","LU1778281490.HKD","BK4139","BK4533","LU0061475181.USD","BIB","LU0109394709.USD","IE00B19Z9P08.USD","IBBQ","LU1093756325.SGD","BK4567","IE00BJJMRZ35.SGD","LU2236285917.USD","LU0058720904.USD","LU2362541273.HKD","IE00BZ9MQY76.HKD","SG9999013999.USD","TBXU","IE0002141913.USD","LU0289739699.SGD","LU2237438978.USD","LU2417539215.USD","IE00BJT1NW94.SGD","BK4532","LU2362541513.USD","VRTX","LU0079474960.USD","LU2456880835.USD","LU0234570918.USD","IE00B19Z3581.USD","IE00B2B36J28.USD","LU2324357040.USD","LU0417517546.SGD","BBH","BK4585","LU0256863811.USD","LU1430594728.SGD","LU1069344957.HKD","LU1585245621.USD","BK4588","LU2362540622.SGD","LU2462157665.USD","LU2089984988.USD","LU2468319806.SGD","SG9999001176.USD","LU1093756168.USD","LU1674673691.USD","PBE","IE0009355771.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141963964","title":"福泰製藥：基於現行關税法規，2026年指引中關税成本影響依然微乎其微","url":"https://stock-news.laohu8.com/highlight/detail?id=1141963964","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141963964?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 04:04","pubTimestamp":1785787449,"startTime":"0","endTime":"0","summary":"福泰制药（Vertex Pharmaceuticals）表示，根据当前已知的关税税率与相关法规，其2026年业绩指引中继续纳入的关税成本影响，仍属微不足道。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BK4139","LU1093756168.USD","LU0823416689.USD","LU2362541273.HKD","SG9999013999.USD","LU1778281490.HKD","BK4532","LU2362541513.USD","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","LU1585245621.USD","IDNA","LU2362540622.SGD","BK4588","BK4585","VRTX","IE00BZ9MQY76.HKD","BBH","LU0109394709.USD","LU2468319806.SGD","SG9999001176.SGD","IE0002141913.USD","LU1674673428.USD","LU0417517546.SGD","IE00B19Z9Z06.USD","IE00BJJMRZ35.SGD","TBXU","BK4567","LU0079474960.USD","LU0234570918.USD","LU0256863811.USD","IE00B19Z3B42.SGD","PBE","LU1430594728.SGD","LU1035775433.USD","LU2237438978.USD","LU0061475181.USD","SGXZ57979304.SGD","GNMX","IBB","LU1674673691.USD","LU2417539215.USD","IE00B894F039.SGD","LU1069344957.HKD","LU1093756325.SGD","LU2456880835.USD","LU2236285917.USD","IE00B19Z9P08.USD","LU2324357040.USD","IBBQ","IE00B4R5TH58.HKD","LU2089984988.USD","IE0002270589.USD","IE0009355771.USD","BK4533","SG9999001176.USD","LU0889565916.HKD","LU0320765992.SGD","LU0432979614.USD","BIB","LU0289739699.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656630972","title":"Vertex憑藉囊性纖維化藥物的強勁表現上調年度營收預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2656630972","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656630972?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 04:02","pubTimestamp":1785787378,"startTime":"0","endTime":"0","summary":"Vertex凭借囊性纤维化药物的强劲表现上调年度营收预期路透8月3日-Vertex Pharmaceuticals周一上调了年度营收预期的上限，此举得益于其囊性纤维化治疗药物需求的强劲增长。Vertex表示，其年度展望未包含待完成的Crinetics收购交易，待交易于第三季度完成后，将提供更新后的预测。该公司表示，这一增长主要得益于囊性纤维化疗法的持续良好表现。Vertex报告称，经调整后的季度每股收益为4.73美元，符合市场预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4T4401T9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU2362541513.USD","LU0432979614.USD","IE00BFTCPJ56.SGD","BK4585","BBH","VRTX","IE0002270589.USD","LU1585245621.USD","GNMX","TBXU","LU0256863811.USD","IDNA","LU2324357040.USD","LU1035775433.USD","IE00B894F039.SGD","LU1430594728.SGD","LU1778281490.HKD","IE00B19Z9P08.USD","BK4532","CRNX","LU0320765992.SGD","BIB","LU1674673428.USD","IE0009355771.USD","SGXZ57979304.SGD","BK4567","IE00BJJMRZ35.SGD","LU0079474960.USD","IE00B4R5TH58.HKD","BK4007","LU2468319806.SGD","IE0002141913.USD","PBE","SG9999001176.USD","LU1069344957.HKD","LU0234570918.USD","LU0417517546.SGD","IE00BZ9MQY76.HKD","LU2362540622.SGD","IBB","LU1093756325.SGD","IBBQ","LU2417539215.USD","SG9999013999.USD","SG9999001176.SGD","LU2362541273.HKD","IE00B19Z3B42.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656031243","title":"加州最高法院在「創新義務」案中裁定吉利德勝訴","url":"https://stock-news.laohu8.com/highlight/detail?id=2656031243","media":"路透中文","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656031243?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 01:02","pubTimestamp":1785776562,"startTime":"0","endTime":"0","summary":"加州最高法院在“创新义务”案中裁定吉利德胜诉路透8月3日-加利福尼亚州最高法院周一就一起案件作出裁决，支持吉利德科学公司GILD.O，该案涉及被视为安全的药物制造商是否必须尝试开发更安全的药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4T4401N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"加州最高法院在“创新义务”案中裁定吉利德胜诉","news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4568","BBH","LU0058720904.USD","BIB","LU1674673428.USD","LU1571399168.USD","IE00BZ1G4Q59.USD","LU1037948897.HKD","LU2089984988.USD","TBXU","IE00B19Z3581.USD","LU2324357040.USD","IE00BKVL7J92.USD","LU0289739699.SGD","IE00BSNM7G36.USD","LU1778281490.HKD","LU0965509010.AUD","IBBQ","LU1585245621.USD","IBB","LU0122379950.USD","LU0965509283.SGD","BK4578","LU0965508806.USD","LU0861579265.USD","LU1023059063.AUD","LU1674673691.USD","IE00B19Z3B42.SGD","IE0002270589.USD","LU1934455194.USD","MEDI","BK4139","BK4585","LU1057294990.SGD","LU0882574055.USD","IE00B3T34201.USD","LU1066051498.USD","LU0823416689.USD","LU1037948541.HKD","BMED","GILD","LU0965509101.SGD","TMED","SG9999015945.SGD","IE00B7SZLL34.SGD","LU2112291526.USD","BK4566","BK4532","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187256046","title":"加州最高法院裁定吉利德科學勝訴，HIV藥物「創新責任」案塵埃落定","url":"https://stock-news.laohu8.com/highlight/detail?id=1187256046","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187256046?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 01:01","pubTimestamp":1785776475,"startTime":"0","endTime":"0","summary":"加州最高法院近期作出裁决，判定吉利德科学在一起涉及HIV药物的“创新责任”案件中胜诉。原告方曾指控吉利德，声称其明知旧款HIV药物存在肾毒性风险，却故意拖延新一代、更安全药物的研发与上市，造成了患者不必要的伤害。对于吉利德而言，这无疑是一场关键胜利，避免了潜在的巨额赔偿和声誉受损。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","LU1057294990.SGD","BK4583","LU1037948541.HKD","IE00B19Z3B42.SGD","LU0861579265.USD","LU1674673428.USD","LU0965508806.USD","LU1061106388.HKD","SG9999015945.SGD","TMED","LU0823416689.USD","LU0320765992.SGD","IE0002270589.USD","BK4578","LU0889565916.HKD","LU1778281490.HKD","BK4139","LU0965509283.SGD","BIB","LU0109394709.USD","IE00BZ1G4Q59.USD","IBBQ","LU1023059063.AUD","LU1934455863.HKD","LU2087621335.USD","MEDI","LU0058720904.USD","LU2112291526.USD","LU0965509101.SGD","LU1571399168.USD","GILD","TBXU","LU0114720955.EUR","LU0289739699.SGD","BK4532","LU1066051498.USD","LU1839511570.USD","LU1066053197.SGD","LU0234570918.USD","IE00B19Z3581.USD","LU0122379950.USD","SG9999015952.SGD","LU2324357040.USD","BK4566","BBH","IE00BKVL7J92.USD","LU1934455194.USD","BK4585","IE00B7SZLL34.SGD","LU0965509010.AUD","LU1430594728.SGD","LU1585245621.USD","BK4588","LU1934455277.USD","LU2468319806.SGD","LU2089984988.USD","SG9999015978.USD","BK4568","BMED","BK4550","LU0882574055.USD","LU1674673691.USD","IE00BSNM7G36.USD","SG9999015986.USD","IBB","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656325798","title":"傑富瑞因索馬圖林面臨的競爭風險，將伊普森評級下調至「表現遜於大盤」","url":"https://stock-news.laohu8.com/highlight/detail?id=2656325798","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656325798?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 15:01","pubTimestamp":1785740464,"startTime":"0","endTime":"0","summary":"BUZZ-杰富瑞因索马图林面临的竞争风险，将伊普森评级下调至“表现逊于大盘”8月3日-** 杰富瑞将法国制药公司伊普森的评级从“中性”下调至“表现逊于大盘”，理由是其Somatuline药物面临长期风险** 该券商预测，受仿制药竞争以及卡穆鲁斯公司带来的压力增大影响，Somatuline在2027年的销售额将下滑20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL4S4400GN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","BBH","IE00B4R5TH58.HKD","IE0009354923.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","PTH","IE00BJJMRZ35.SGD","CANC","LU0320765992.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4139","IE0009355771.USD","RVMD","IDNA","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656134416","title":"安進7月遭網絡攻擊 部分患者信息被盜","url":"https://stock-news.laohu8.com/highlight/detail?id=2656134416","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656134416?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 10:28","pubTimestamp":1785724120,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1057294990.SGD","IE00B4R5TH58.HKD","PJP","IE00BFTCPJ56.SGD","BK4599","LU2242646821.SGD","LU1061106388.HKD","BK4581","UCYB","LU0320765992.SGD","LU0889565916.HKD","BK4139","BK4533","BK4534","BIB","LU0109394709.USD","LU1023059063.AUD","IBBQ","IE00BJJMRZ35.SGD","LU0058720904.USD","LU2112291526.USD","SPAM","LU1571399168.USD","TBXU","IE0002141913.USD","LU0289739699.SGD","WCBR","HAKY","IE00BJT1NW94.SGD","LU2242652126.USD","AMGN","LU1983299246.USD","LU0122379950.USD","IE00B2B36J28.USD","SG9999001440.SGD","BK4566","BBH","LU0868494617.USD","BK4585","LU2468319806.SGD","BK4588","LU2089984988.USD","PBE","IE0009355771.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656139948","title":"安進：部分數據已遭竊取，其中包括專有數據、患者受保護健康信息及其他信息。","url":"https://stock-news.laohu8.com/highlight/detail?id=2656139948","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656139948?lang=zh_tw&edition=fundamental","pubTime":"2026-08-01 04:12","pubTimestamp":1785528741,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0122379950.USD","BBH","LU1023059063.AUD","TBXU","LU1057294990.SGD","IE0002141913.USD","LU1983299246.USD","AMGN","LU2242652126.USD","IBB","LU0889565916.HKD","PBE","IE00B2B36J28.USD","LU0289739699.SGD","LU2089984988.USD","BK4581","BK4588","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0058720904.USD","LU0109394709.USD","LU0868494617.USD","LU2242646821.SGD","LU1571399168.USD","BK4533","IBBQ","LU0320765992.SGD","IE00BJT1NW94.SGD","PJP","LU1061106388.HKD","SG9999001440.SGD","BK4566","BK4585","BIB","IE00BJJMRZ35.SGD","BK4534","LU2112291526.USD","LU2468319806.SGD","IE00B4R5TH58.HKD","BK4599","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":198,"code":"91000000","status":"200"}]}}